Drug intelligence / Profile preview

VEN BETA

Development stage
Preclinical
Lead developer
Ventria Bioscience
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

VEN BETA is an investigational recombinant protein therapeutic being developed by Ventria Bioscience for the treatment of gastroenteritis. The product is manufactured using Ventria's proprietary ExpressTec platform, which utilizes genetically modified rice grains to express human proteins at a high scale and low cost. While specific details regarding the protein's identity are limited in public disclosures, VEN BETA is part of a therapeutic pipeline focused on infectious and inflammatory diseases of the gastrointestinal tract. It is likely a recombinant version of a human antimicrobial or immunomodulatory protein, such as a defensin, designed to enhance the gut's innate immune response and combat enteric pathogens. The candidate is currently in the early stages of development with a pending clinical phase.

Other names
VEN + BETA

Beyond the preview

Go deeper on VEN BETA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VEN BETA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call